4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-018775
Director sold 12,866 shares at $8.04 ($103,443)
- Director acquired 16,745 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hutson Nancy J · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-13 | Grant or award : show line 1 in the form | +16,745 | 94,684 | D | ||
| 2023-06-14 | Sale : show line 2 in the form | −12,866 | $8.04 | $103,443 | 81,818 | D |
| Open-market sales · 12,866 sh · avg $8.04 · $103,443 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-13 | Grant or award : show line 3 in the form Automatic Stock Option Grant | +39,072 | 39,072 | D |
Loading xslF345X04/form4.xml…